New York State Common Retirement Fund
DYN icon

New York State Common Retirement Fund’s Dyne Therapeutics DYN Stock Holding History

New York State Common Retirement Fund’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.91M Buy
355,953
+22,456
+7% +$417K 0.01% 889
2026
Q1 		$6.05M Buy
333,497
+254,235
+321% +$4.38M 0.01% 939
2025
Q4 		$1.55M Buy
79,262
+44,589
+129% +$844K ﹤0.01% 1506
2025
Q3 		$439K Buy
34,673
+9,700
+39% +$111K ﹤0.01% 1993
2025
Q2 		$238K Hold
24,973
– – ﹤0.01% 2184
2025
Q1 		$261K Hold
24,973
– – ﹤0.01% 2122
2024
Q4 		$588K Hold
24,973
– – ﹤0.01% 1884
2024
Q3 		$897K Sell
24,973
-8,300
-25% -$330K ﹤0.01% 1723
2024
Q2 		$1.17M Buy
33,273
+13,330
+67% +$387K ﹤0.01% 1686
2024
Q1 		$566K Buy
19,943
+1,351
+7% +$30.6K ﹤0.01% 2027
2023
Q4 		$247K Buy
18,592
+2,244
+14% +$21.9K ﹤0.01% 2371
2023
Q3 		$146K Buy
16,348
+216
+1% +$2.33K ﹤0.01% 2556
2023
Q2 		$181K Sell
16,132
-3,546
-18% -$41.8K ﹤0.01% 2542
2023
Q1 		$227K Hold
19,678
– – ﹤0.01% 2532
2022
Q4 		$228K Buy
19,678
+1
+0% +$12 ﹤0.01% 2678
2022
Q3 		$250K Buy
19,677
+78
+0.4% +$894 ﹤0.01% 2670
2022
Q2 		$135K Sell
19,599
-70
-0.4% -$482 ﹤0.01% 2967
2022
Q1 		$190K Buy
19,669
+25
+0.1% +$213 ﹤0.01% 2835
2021
Q4 		$234K Sell
19,644
-74
-0.4% -$1.04K ﹤0.01% 2811
2021
Q3 		$320K Sell
19,718
-6,112
-24% -$108K ﹤0.01% 2689
2021
Q2 		$543K Buy
25,830
+15,430
+148% +$290K ﹤0.01% 2556
2021
Q1 		$162K Hold
10,400
– – ﹤0.01% 2912
2020
Q4 		$218K Buy
+10,400
New +$206K ﹤0.01% 2726

Other funds holding DYN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

New York State Common Retirement Fund's DYN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Dyne Therapeutics (DYN) stake by 6.7% in Q2 2026, buying an estimated $417K and bringing the position to 355,953 shares worth $7.91M. The position accounts for 0.01% of the portfolio, ranked #889.

New York State Common Retirement Fund first reported a position in DYN in Q4 2020 and has held it in 23 quarters since. 47 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • New York State Common Retirement Fund held 355,953 shares of Dyne Therapeutics worth $7.91M as of Q2 2026.
  • New York State Common Retirement Fund bought 22,456 Dyne Therapeutics shares in Q2 2026, an estimated $417K.
  • Dyne Therapeutics made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #889 holding.
  • New York State Common Retirement Fund first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 47 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.